Prostate Cancer Reports
54

Volume 5 Supplement 4
April 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Supplement 4, April


CONTENTS



CASE REPORTS
CLASSIFICATION
DIAGNOSIS AND EVALUATION
EPIDEMIOLOGY, RISK FACTORS AND PREVENTION
ETIOLOGY, PATHOGENESIS AND PATHOLOGY
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT





CASE REPORTS








CLASSIFICATION






DIAGNOSIS AND EVALUATION








EPIDEMIOLOGY, RISK FACTORS AND PREVENTION








ETIOLOGY, PATHOGENESIS AND PATHOLOGY








FOLLOW-UP AND QUALITY OF LIFE








INTEGRATIVE MEDICINE








OVERALL MANAGEMENT








PROGNOSIS AND OUTCOMES



Ahn JH, Lee JZ, Chung MK, Ha HK
Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL.
J Korean Med Sci. 2014 Mar;29(3):338-42. doi: 10.3346/jkms.2014.29.3.338. Epub 2014 Feb 27.
Source | Abstract | Full text | Similar articles




Aragon-Ching JB, Siegel RS, Frazier H 2nd, Andrawis R, Hendricks F, Phillips M, Jarrett T, Guebre-Xabiher H, Patierno S, Simmens SJ.
Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
Clin Genitourin Cancer. 2015 Apr 18. pii: S1558-7673(15)00075-0. doi: 10.1016/j.clgc.2015.04.003. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ellison LF.
Adjusting relative survival estimates for cancer mortality in the general population.
Health Rep. 2014 Nov 19;25(11):3-9.
Source | Abstract | Full text | Similar articles




Garzotto M, Beer TM, Hudson RG, Peters L, Hsieh YC, Barrera E, Klein T, Mori M.
Improved detection of prostate cancer using classification and regression tree analysis.
J Clin Oncol. 2005 Jul 1;23(19):4322-9. Epub 2005 Mar 21.
Source | Abstract | Full text | Similar articles




Green DA, Osterberg EC, Xylinas E, Rink M, Karakiewicz PI, Scherr DS, Shariat SF.
Predictive tools for prostate cancer staging, treatment response and outcomes.
Arch Esp Urol. 2012 Nov;65(9):787-807.
Source | Abstract | Full text | Similar articles




Hamada R, Nakashima J, Ohori M, Ohno Y, Komori O, Yoshioka K, Tachibana M.
Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Int J Clin Oncol. 2016 Jun;21(3):595-600. doi: 10.1007/s10147-015-0923-3. Epub 2015 Nov 19. Erratum in:
Int J Clin Oncol. 2016 Jun;21(3):601.
Source | Abstract | Full text | Similar articles




Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV.
CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Oncotarget. 2015 Jan 30;6(3):1889-97.
Source | Abstract | Full text | Similar articles




Léon P, Seisen T, Cussenot O, Drouin SJ, Cattarino S, Compérat E, Renard-Penna R, Mozer P, Bitker MO, Rouprêt M.
Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
Urol Oncol. 2015 Jan 13. pii: S1078-1439(14)00399-8. doi: 10.1016/j.urolonc.2014.11.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Redorta JP, Graefen M, Guazzoni G.
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy.
Eur Urol. 2013 Dec 16. pii: S0302-2838(13)01326-2. doi: 10.1016/j.eururo.2013.12.005. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




McPhail S, Johnson S, Greenberg D, Peake M, Rous B.
Stage at diagnosis and early mortality from cancer in England.
Br J Cancer. 2015 Mar 31;112 Suppl 1:S108-15. doi: 10.1038/bjc.2015.49.
Source | Abstract | Full text | Similar articles




Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ.
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
Cancer. 2014 Jan 15;120(2):197-204. doi: 10.1002/cncr.28423. Epub 2013 Oct 11.
Source | Abstract | Full text | Similar articles



Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW.
Assessing individual risk for prostate cancer.
J Clin Oncol. 2007 Aug 20;25(24):3582-8.
Source | Abstract | Full text | Similar articles



Nowroozi MR, Amini S, Kasaeian A, Zavarehei MJ, Eshraghian MR, Ayati M.
Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
Asia Pac J Clin Oncol. 2014 Mar 29. doi: 10.1111/ajco.12186. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pavese JM, Bergan RC.
Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.
Cancer Lett. 2014 Oct 1;352(2):179-86. doi: 10.1016/j.canlet.2014.06.012. Epub 2014 Jul 10.
Source | Abstract | Full text | Related citations




Pietzak EJ 3rd, Kabarriti AE, Mucksavage P, Bavaria T, Van Arsdalen K, Malkowicz SB, Wein AJ, Guzzo TJ.
The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.
Urology. 2014 Dec;84(6):1442-7. doi: 10.1016/j.urology.2014.04.066. Epub 2014 Oct 5.
Source | Abstract | Full text | Similar articles



Ross RW, Kantoff PW.
Predicting outcomes in prostate cancer: how many more nomograms do we need?
J Clin Oncol. 2007 Aug 20;25(24):3563-4.
Source | Abstract | Full text | Similar articles




Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS.
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
J Urol. 2015 Feb 21. pii: S0022-5347(15)00394-8. doi: 10.1016/j.juro.2015.02.084. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT.
Critical review of prostate cancer predictive tools.
Future Oncol. 2009 Dec;5(10):1555-84. doi: 10.2217/fon.09.121.
Source | Abstract | Full text | Similar articles




Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW.
An updated catalog of prostate cancer predictive tools.
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
Source | Abstract | Full text | Similar articles




Shariat SF, Karakiewicz PI, Margulis V, Kattan MW.
Inventory of prostate cancer predictive tools.
Curr Opin Urol. 2008 May;18(3):279-96. doi: 10.1097/MOU.0b013e3282f9b3e5.
Source | Abstract | Full text | Similar articles




Steinberger E, Kollmeier M, McBride S, Novak C, Pei X, Zelefsky MJ.
Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity.
BJU Int. 2014 Oct 23. doi: 10.1111/bju.12969. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
J Urol. 2014 Jun;191(6):1784. doi: 10.1016/j.juro.2014.03.065. Epub 2014 Mar 20.
Source | Abstract | Full text | Similar articles



Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ, Thompson Jr IM.
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.
Cancer. 2013 May 29. doi: 10.1002/cncr.28114. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF, Jeldres C, Graefen M, Bénard F, McCormack M, Valiquette L, Karakiewicz PI.
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
J Clin Oncol. 2007 Aug 20;25(24):3576-81.
Source | Abstract | Full text | Similar articles




Weiner AB, Patel SG, Eggener SE.
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
Urol Oncol. 2015 Jan 23. pii: S1078-1439(14)00465-7. doi: 10.1016/j.urolonc.2014.12.012. [Epub ahead of print]
Source | Abstract | Full text | Related citations





TREATMENT










25






Source | Abstract | Full text |